Schott: Expansion Of Syringe Manufacturing Capacity®

SCHOTT forma vitrum has tripled its production capacity with glass and polymer syringes in St. Gallen, Switzerland.

The international manufacturer of pharmaceutical packaging has invested around 20 million euros to glass forming, infrastructure, clean rooms and WFI facilities (water for injection purposes).

The new production facilities are based on state-of-the-art technology. In addition, several accompanying measures were taken to further improve the flow of goods and optimize customer service following expansion.

600450 Schott: Expansion Of Syringe Manufacturing Capacity® glassonweb.com

See more news about:

Others also read

SCHOTT is introducing a new, innovative portfolio of structured glass substrates that offers highly accurate and versatile features: FLEXINITY™.
Thin glass is revolutionising the performance spectrum of glass and glass panes.
The latest laminated, anti-glare cover glass from SCHOTT – CONTURAN® IR Protect – deflects more than 80 percent of infrared (IR) and ultraviolet (UV) radiation.
A quarter of a century ago, the German technology group SCHOTT followed a customer to San Luis Potosí, and a Latin American success story began
Ultra-thin smartphone protective glass from SCHOTT now available in retail.
SCHOTT technology group opens its “Opportunity Lab” to the public for fresh ideas.

Add new comment